Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
11. 69
+0.1
+0.8628%
¥
6.34B Market Cap
- P/E Ratio
0.34% Div Yield
11.39M Volume
- Eps
¥ 11.59
Previous Close Want to track 301211 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211) Statistics
Valuation metrics
Market Cap 6.34B
Enterprise value 4.41B
Trailing P/E (ttm) 138.9
Forward P/E -
PEG ratio -2.9
Price/Sales (ttm) 10.53
Price/Book (mrq) 2.12
Enterprise Value/Revenue 9.6
Enterprise Value/EBITDA 65.39
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 7.96M
Average volume (90 days) 10.34M
Price summary
52-Week low 9.01
52-Week high 16.95
Beta -
50-Day moving average 11.27
200-Day moving average 11.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.06
Trailing annual dividend yield 0.0052%
5-Year annual dividend yield -
Payout ratio 2.13
Dividend Date 12 Jun 2026
Ex-Dividend Date 12 Jun 2026
Last split factor 1:1
Last split Date 27 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin -0%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.69
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 17.18%
Book value per share (mrq) 5.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
